Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03233191 · ClinicalTrials.gov registry record · Phase 3
Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer
A Phase 3 study of Breast Screening, sponsored by ECOG-ACRIN Cancer Research Group.
- Active
- Registry status
- Phase 3
- Development phase
- 108,508
- Enrollment target
- 20
- Study locations
NCT03233191 is a Phase 3 study of Breast Screening that is active but no longer recruiting, run by ECOG-ACRIN Cancer Research Group. The registered enrollment target is 108,508 participants. The trial reports 20 study locations across 6 states.
The verdict
NCT03233191, a Phase 3 study of Breast Screening, is active but no longer recruiting, sponsored by ECOG-ACRIN Cancer Research Group.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 108,508 participants
- Enrollment target
- 20
- Study locations
Study Summary
This randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer. Screening for breast cancer with tomosynthesis mammography may be superior to digital mammography for breast cancer screening and may help reduce the need for additional imaging or treatment.
Conditions Studied
Interventions
- OTHER Laboratory Biomarker Analysis
- PROCEDURE Digital Tomosynthesis Mammography
- PROCEDURE Digital Mammography
Study Locations (20)
Colorado
- UCHealth University of Colorado Hospital - Aurora
- Penrose-Saint Francis Healthcare - Colorado Springs
- The Women's Imaging Center - Denver
- Radiology Imaging Associates - Englewood
- UCHealth Highlands Ranch Hospital - Highlands Ranch
- UCHealth Lone Tree Health Center - Lone Tree
Arizona
- Banner-University Medical Center Phoenix - Phoenix
- University of Arizona College of Medicine Phoenix - Phoenix
- Valleywise Comprehensive Health Center - Phoenix - Phoenix
- Mayo Clinic Hospital in Arizona - Phoenix
- Scottsdale Medical Imaging Limited - Scottsdale
California
- Kern Radiology Medical Group Inc - Bakersfield
- Los Angeles General Medical Center - Los Angeles
- USC / Norris Comprehensive Cancer Center - Los Angeles
- Kaiser Permanente-Modesto - Modesto
- Zuckerberg San Francisco General Hospital - San Francisco
Alabama
- University of Alabama at Birmingham Cancer Center - Birmingham
- Mobile Infirmary Medical Center - Mobile
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Delaware
- Helen F Graham Cancer Center - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108,508 participants |
| Start Date | 2017-09-28 |
| Est. Completion | 2030-12-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03233191
The ClinicalTrials.gov registry entry for NCT03233191 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 108,508 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ECOG-ACRIN Cancer Research Group, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Screening appearing as the primary indexed condition, and to 3 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT03233191 reports 20 study locations spanning 6 distinct geographic areas - top geographies include Colorado, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT03233191 about?
NCT03233191 is a clinical study titled "Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer". This randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer. Screening for breast cancer with tomosynthesis mammography may be superior to digital mammography for breast cancer screening and may help reduce the need for ad...
What is the current status of trial NCT03233191?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 108,508 participants. The study started on 2017-09-28. Estimated completion is 2030-12-31.
What conditions does trial NCT03233191 study?
This clinical trial studies the following conditions: Breast Screening.
What interventions are being tested in trial NCT03233191?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Digital Tomosynthesis Mammography (PROCEDURE), Digital Mammography (PROCEDURE).
Who is sponsoring clinical trial NCT03233191?
This trial is sponsored by ECOG-ACRIN Cancer Research Group, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03233191 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.